MedPath

Effect of Non-invasive Neurostimulation on Variability OF HEART RATE IN PATIENTS WITH HEART FAILURE.

Not Applicable
Recruiting
Conditions
Heart Failure
Interventions
Device: high definition transcranial direct current stimulation
Registration Number
NCT05944874
Lead Sponsor
Federal University of Paraíba
Brief Summary

This study is a clinical trial, and may also be referred to as a "before and after" study, in which all subjects receive the same treatment and their condition is checked before initiation and after various times of treatment. This study will be carried out at the Laboratory of Physiotherapy in Cardiorespiratory Research, located in the building of the postgraduate course in physiotherapy at the Health Sciences Center (CCS) of the Federal University of Parahyba (UFPB), from May 2023 to May 2020. 2024. After screening, patients will undergo assessment and anthropometric measurements. Subsequently, interventions will be carried out

Detailed Description

The patients will perform three sessions of HD-TDCS (stimulation, inhibition and Shan) of twenty minutes with an intensity of three milliamps in the left temporal cortex. Before and after each session, patients will perform the six-minute walk test. Heart rate variability (HRV) will be evaluated throughout the protocol through Holter (3-channel). At the end, the perception of exertion and the level of dyspnea of the patient, distance covered and blood pressure will be evaluated.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • clinical diagnosis of heart failure;
  • over eighteen years old;
  • classified in functional class II and III of the New York Heart Association.
Exclusion Criteria
  • Patients with neurological or pulmonary diseases;
  • Patients with cognitive alterations that make it impossible to execute commands;
  • with physical limitations that prevent the performance of the exercise protocol.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
HD- TDCS (stimulation)high definition transcranial direct current stimulationPatients will perform a session (stimulation) of HD-TDCS of twenty minutes with intensity of 3 milliamps in the left temporal cortex. Before and after each session, patients will perform the six-minute walk test. Heart rate variability (HRV) will be evaluated throughout the protocol through Holter (3-channel). At the end, the perception of exertion and the level of dyspnea of the patient, distance covered and blood pressure will be evaluated.
HD- TDCS (shan)high definition transcranial direct current stimulationPatients will perform a twenty-minute session (SHAN) of HD-TDCS with an intensity of 3 milliamps in the left temporal cortex. Before and after each session, patients will perform the six-minute walk test. Heart rate variability (HRV) will be evaluated throughout the protocol through Holter (3-channel). At the end, the perception of exertion and the level of dyspnea of the patient, distance covered and blood pressure will be evaluated.
HD- TDCS (inhibition)high definition transcranial direct current stimulationPatients will perform a session (inhibition) of HD-TDCS of twenty minutes with intensity of 3 milliamps in the left temporal cortex. Before and after each session, patients will perform the six-minute walk test. Heart rate variability (HRV) will be evaluated throughout the protocol through Holter (3-channel). At the end, the perception of exertion and the level of dyspnea of the patient, distance covered and blood pressure will be evaluated.
Primary Outcome Measures
NameTimeMethod
Travelled distanceday one

To analyze the distance walked by these patients after the six-minute walk test after the application of HD-Tdcs

heart rate variabilityday one

To evaluate the effects of HD-TDCS on the left temporal lobe - T3 on heart rate variability during the six-minute walk test in patients with heart failure

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Lauro Wanderley

🇧🇷

João Pessoa, Paraíba, Brazil

© Copyright 2025. All Rights Reserved by MedPath